Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancers.
Nanoparticle-mediated tumor cell expression of mIL-12 via systemic gene delivery treats syngeneic models of murine lung cancers.
复制标题
DOI:
10.1038/s41598-021-89124-4
复制
发表时间:
2021-05-06
影响因子:
4.6
通讯作者:
Minn I
中科院分区:
文献类型:
--
作者:
Ahn HH;Carrington C;Hu Y;Liu HW;Ng C;Nam H;Park A;Stace C;West W;Mao HQ;Pomper MG;Ullman CG;Minn I
Treatment of cancers in the lung remains a critical challenge in the clinic for which gene therapy could offer valuable options. We describe an effective approach through systemic injection of engineered polymer/DNA nanoparticles that mediate tumor-specific expression of a therapeutic gene, under the control of the cancer-selective progression elevated gene 3 (PEG-3) promoter, to treat tumors in the lungs of diseased mice. A clinically tested, untargeted, polyethylenimine carrier was selected to aid rapid transition to clinical studies, and a CpG-free plasmid backbone and coding sequences were used to reduce inflammation. Intravenous administration of nanoparticles expressing murine single-chain interleukin 12, under the control of PEG-3 promoter, significantly improved the survival of mice in both an orthotopic and a metastatic model of lung cancer with no marked symptoms of systemic toxicity. These outcomes achieved using clinically relevant nanoparticle components raises the promise of translation to human therapy.
登录
查看更多内容
影响因子:
6.2
作者:
Bode C;Zhao G;Steinhagen F;Kinjo T;Klinman DM
通讯作者:
Klinman DM
影响因子:
3.3
作者:
Forde PM;Ettinger DS
通讯作者:
Ettinger DS
影响因子:
5.2
作者:
Eissa IR;Bustos-Villalobos I;Ichinose T;Matsumura S;Naoe Y;Miyajima N;Morimoto D;Mukoyama N;Zhiwen W;Tanaka M;Hasegawa H;Sumigama S;Aleksic B;Kodera Y;Kasuya H
通讯作者:
Kasuya H
影响因子:
46.9
作者:
Lieschke, GJ;Rao, PK;Mulligan, RC
通讯作者:
Mulligan, RC
影响因子:
0.7
作者:
Loi, Monica;Di Paolo, Daniela;Pastorino, Fabio
通讯作者:
Pastorino, Fabio